Basic Information
| LncRNA/CircRNA Name | lnc-C22orf32-1 |
| Synonyms | LINC01315, lnc-C22orf32-1 |
| Region | GRCh38_22:42364400-42369236 |
| Ensemble | ENSG00000229891 |
| Refseq | NR_120595 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | nasopharyngeal cancer |
| ICD-0-3 | C11 |
| Methods | qPCR |
| Sample | nasopharyngeal carcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | The expression levels of lncRNA C22orf32-1 in NPC tissues and an NPC cell line were upregulated. lncRNA C22orf32-1 promoted the proliferation, migration and invasion of NPC cells, and reduced the apoptosis of NPC cells. |
| Pubmed ID | 28588717 |
| Year | 2017 |
| Title | lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma |
External Links
| Links for lnc-C22orf32-1 | GenBank HGNC NONCODE |
| Links for nasopharyngeal cancer | OMIM COSMIC |